Back
ESC Premium Access

Cardiac amyloidosis in patients undergoing aortic valve replacement for aortic stenosis

Session: The 3I Role of Metabolic Imaging: Ischemia, Infection and Inflammation
Topic: Technology and Tracers
Speaker: Doctor S. Fukuzawa (Funabashi, JP)
Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Shigeru Fukuzawa

Funabashi Municipal Medical Center, Funabashi (Japan)
0 follower

6 more presentations in this session

The GLP-1 receptor agonist Semaglutide decreases vascular inflammation in a rabbit model of advanced atherosclerosis

Speaker: Doctor J. Kildevang Jensen (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

High-risk plaque burdens myocardial flow reserve in intermediate coronary artery disease: hybrid analysis of 13N-ammonia PET and coronary CT angiography.

Speaker: Doctor A. Yamamoto (Shinjyuku, JP)

Access
Abstract
Slides
Thumbnail

Prognostic role of positron emission tomography in patients with known or suspected cardiac sarcoidosis. a systematic review and meta-analysis

Speaker: Doctor K. Bhatia (New York, US)

Access
Abstract
Slides
Thumbnail

Splenic switch off as a novel marker for adenosine response in 13N-ammonia PET myocardial perfusion imaging - a pilot study.

Speaker: Doctor A. Bakula (Bern, CH)

Access
Abstract
Slides
Thumbnail

Prediction for cardiac prognosis in patients with congestive heart failure by machine learning on dual-isotope myocardial semiconductor SPECT

Speaker: Doctor M. Shimizu (Yokohama, JP)

Access
Abstract
Slides
Thumbnail

Access the full session

The 3I Role of Metabolic Imaging: Ischemia, Infection and Inflammation

Speakers: Doctor S. Fukuzawa, Doctor J. Kildevang Jensen, Doctor A. Yamamoto, Doctor K. Bhatia, Doctor A. Bakula...
Access
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb